| Correlations between pathological and SUVmax values | ||
Number (%) | SUVmax | P value | |
Tumor invasive size |
|
|
|
T1 | 36 (49.3) | 3.95 ± 3.28 | <0.001 |
T2 | 37 (50.7) | 7.23 ± 4.10 |
|
ER status |
|
|
|
Positive | 56 (76.7) | 4.62 ± 3.61 | <0.001 |
Negative | 17 (23.3) | 8.90 ± 3.73 |
|
PR status |
|
|
|
Positive | 42 (57.5) | 4.75 ± 3.94 | 0.0134 |
Negative | 31 (42.5) | 6.79 ± 3.95 |
|
HER2 status |
|
|
|
Positive | 10 (13.7) | 8.66 ± 4.98 | 0.0176 |
Negative | 63 (86.3) | 5.17 ± 3.70 |
|
Ki-67 index (%) |
|
|
|
<14 | 28 (38.4) | 3.24 ± 2.58 | <0.001 |
≥14 | 45 (61.6) | 7.10 ± 4.11 |
|
Nuclear grade |
|
|
|
1 | 38 (52.1) | 3.85 ± 3.15 | <0.001 |
2 | 17 (23.3) | 6.79 ± 3.50 |
|
3 | 18 (24.6) | 7.60 ± 3.73 |
|